Stay updated on Pembrolizumab Combo in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Metastatic NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.1%
    Check dated 2025-01-19T22:06:08.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.
    Difference
    0.2%
    Check dated 2025-01-12T17:34:18.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    No Change Detected
  6. Check
    42 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.1%
    Check dated 2024-12-14T22:32:43.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, while removing the previous wording about those conducting the study.
    Difference
    2%
    Check dated 2024-12-07T14:11:55.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    Several key URLs related to genetics, lung cancer, and clinical trials have been removed, indicating a significant reduction in available resources for these topics.
    Difference
    4%
    Check dated 2024-11-23T04:26:54.000Z thumbnail image
  9. Check
    71 days ago
    Change Detected
    Summary
    The website has been updated to version 2.12.2, adding several new resources related to lung cancer, including links to MedlinePlus and ClinicalTrials.gov, while removing the previous version 2.12.1.
    Difference
    4%
    Check dated 2024-11-15T23:03:19.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic NSCLC Clinical Trial page.